DR

Deepika Ravi Belani

Active Director Director DIN 01888442
DIN 01888442 First appointment May 2004 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2004
Shareholding value •••• Premium profile

About Deepika Ravi Belani

Data last updated:

Deepika Ravi Belani is a Director at Enoch Pharmaceuticals Private Limited (since 2004). The company operates in Chemicals. Enoch Pharmaceuticals Private Limited reported revenue of ₹1.7 Lakh (FY 2020).

DIN 01888442
Primary Designation Director
Industry Chemicals
First Appointment 05 May 2004
Oldest Company Age 32 yrs
Largest company Enoch Pharmaceuticals Private Limited · ₹1.7 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 May 20041994₹1.7 Lakh (FY 2020)Active

Board colleagues of Deepika Ravi Belani

Directorship timeline

Open interactive timeline →
Enoch Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deepika Ravi Belani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepika Ravi Belani

Deepika Ravi Belani currently holds 1 directorship: Enoch Pharmaceuticals Private Limited (Director, since 05 May 2004, revenue ₹1.7 Lakh (FY 2020)).

Deepika Ravi Belani was first appointed on 05 May 2004 as Director at Enoch Pharmaceuticals Private Limited.

The current boards of Deepika Ravi Belani's companies include Ravi Chetan Belani (Enoch Pharmaceuticals Private Limited), Seema Ravi Belani (Enoch Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available